Sherry is the Senior Vice President, Corporate Intellectual Property of GlaxoSmithKline, where she serves as the worldwide head of patents and trademarks for the company for both transactional and litigation matters. Sherry joined GSK in September 2006. Prior to that, she was a partner in and founder of the Biotechnology and Pharmaceutical Intellectual Property Practice at King & Spalding LLP, where she represented companies, foundations and universities in connection with patent prosecution, litigation, contracts, licensing and other corporate intellectual property issues relating to pharmaceutical, biotechnology and chemical inventions. Sherry received her B.S in chemistry and her M.S. in organic chemistry. Prior to attending law school, she spent several years at SmithKline Beecham (now GlaxoSmithKline) as a pharmaceutical synthetic chemist.